Life Science Investing Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Life Science Investing Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy in Sanfilippo Syndrome Type B
Life Science Investing Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Life Science Investing Spruce Biosciences Announces Integrated Long-Term Clinical Data of Tralesinidase Alfa Enzyme Replacement Therapy Demonstrating Profound and Durable Efficacy and Safety in Patients with Sanfilippo Syndrome Type B
Walker Lane Resources Ltd. Announces Precision Geosurveys Contracted to Complete an Airborne Geophysical Survey at its Silver Mountain Project, Walker Lane Gold Trend, Nevada
Nine Mile Metals Announces Completion of DDH WD-25-01 and Confirms Two Zones of VMS Mineralization at the Wedge Project
Forte Minerals Commences First-Ever Drilling at the Pucarini High-Sulfidation Gold Project, Puno, Peru
Homerun Resources Inc. Announces First Commercial Installation of "The Hub" AI Energy Management System on a Risen Battery Storage Asset